← Open Payments lookup

CAITLIN MATSUMOTO: Open Payments

NPI 1295104602 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,141 in 123 payments from 37 companies in 2025. Trend: 2023 $3,172 · 2024 $3,045 · 2025 $3,141

Food & beverage: $3,141
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP21$611
Genentech USA, Inc.16$293
GlaxoSmithKline, LLC.10$230
Regeneron Healthcare Solutions, Inc.6$185
Novartis Pharmaceuticals Corporation7$155
Daiichi Sankyo Inc.5$125
Incyte Corporation4$98
Rigel Pharmaceuticals, Inc.4$91
PFIZER INC.4$84
Merck Sharp & Dohme LLC3$84

Products named: ENHERTU, LYNPARZA, LIBTAYO, OJJAARA, Itovebi, TAVALISSE, SCEMBLIX, KEYTRUDA.

Industry payments across CA — which companies pay providers there.